Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
FIVE Indian generic drugmakers, including Cipla and Dr Reddy's Laboratories, have said that they would jointly conduct a clinical trial in India for Merck & Co's experimental anti-viral drug to treat mild Covid-19 in non-hospitalised patients.
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, Molnupiravir, hastening its availability in India to address a new wave of infections in the country.
The partnership gave the companies license to make and supply Molnupiravir to India and more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies, Merck said in late April.
On Tuesday (29), the Indian companies said they would jointly sponsor, supervise and monitor the clinical trial in the country, expected to take place between June and September this year in 1,200 patients.
The trial will be conducted following the approval of its protocol by the Drugs Controller General of India and the companies will independently approach regulatory authorities for approval to manufacture and supply molnupiravir in India after the trial's completion.
Coronavirus cases in India have declined from a devastating peak in April and May. However, health experts have said that the country should brace for a third wave by October.
Molnupiravir is currently being tested in a global late-stage study by Merck and partner Ridgeback Biotherapeutics for the treatment of non-hospitalized Covid-19 patients, with the data from the study expected in the fall of 2021.
India on Wednesday (30) reported 45,951 new Covid-19 infections over the past 24 hours, data from the health ministry showed.
India's coronavirus-related deaths rose by 817 overnight, it added.
The original Hermes Birkin bag sold for £7.4m at Sotheby’s Paris.
It belonged to British actress and singer Jane Birkin.
The handbag is now the most valuable ever sold at auction.
It ranks as the second most expensive fashion item sold globally.
A record-breaking sale
The original Hermes Birkin handbag, once owned by British actress and singer Jane Birkin, has been sold for £7.4 million at a Sotheby’s auction in Paris, setting a new world record for the most valuable handbag ever sold at auction.
The sale, held on Thursday, saw the iconic fashion item exceed all expectations, with Sotheby’s calling it “a startling demonstration of the power of a legend.” The bag is now also the second most expensive fashion item ever sold at auction, following the £24 million paid for Judy Garland’s ruby red slippers from The Wizard of Oz in 2024.
The origin of the Birkin
Jane Birkin, a celebrated figure in French and British cinema from the 1960s onwards, inspired the creation of the handbag during a chance encounter in 1981. She was seated next to Jean-Louis Dumas, then artistic director at Hermes, on an Air France flight. Using a wicker basket as her carry-on, Birkin remarked that handbags at the time were too small for her needs.
In response, Dumas began sketching potential designs with Birkin on the back of an airline sick bag. Hermes introduced a prototype in 1985 and asked for Birkin’s permission to name the new style after her. The design quickly gained traction and evolved into a status symbol within the fashion world.
Cultural significance and celebrity appeal
Since its launch, the Birkin bag has been associated with luxury and exclusivity. It has been carried by global celebrities including Kate Moss, Victoria Beckham, Khloe Kardashian and Jennifer Lopez.
Speaking about the sale, Morgane Halimi, Sotheby’s global head of handbags and fashion, said: “It is a startling demonstration of the power of a legend and its capacity to ignite the passion and desire of collectors seeking exceptional items with unique provenance.”
Previous record and global recognition
Before this auction, the highest-selling handbag was the Hermes white Himalaya niloticus crocodile diamond retourne Kelly 28, which sold for £380,000 in 2021. The sale of the original Birkin now marks a defining moment in both fashion history and the luxury collectibles market.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
This is also part of Mattel’s mission to extend the boundaries of imaginative play
The doll features a glucose monitor, insulin pump and CGM app
Created in collaboration with type 1 diabetes charity Breakthrough T1D
Part of Mattel’s broader push for inclusivity and representation in toys
Barbie with type 1 diabetes joins inclusive fashionistas range
Mattel has launched its first diabetes Barbie doll, designed to represent children with type 1 diabetes and promote greater inclusivity in children’s toys.
The new addition to the Barbie Fashionistas line comes with realistic medical features including a continuous glucose monitor (CGM) on her arm, secured with heart-shaped medical tape, and an insulin pump to help manage her blood sugar levels. She also carries a smartphone with a CGM app to monitor glucose throughout the day, and a bag large enough to store snacks and other essentials.
Designed in partnership with Breakthrough T1D
The diabetes Barbie doll was developed in collaboration with Breakthrough T1D, a global not-for-profit organisation supporting people with type 1 diabetes (T1D). The autoimmune condition typically develops in childhood and requires patients to monitor their blood glucose and take insulin regularly.
Krista Berger, senior vice-president of Barbie and global head of dolls, described the launch as “an important step in our commitment to inclusivity and representation.”
“Barbie helps shape children’s early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love,” she said.
Karen Addington, CEO of Breakthrough T1D UK, welcomed the collaboration: “I’m absolutely thrilled that Barbie now includes a doll with type 1 diabetes. For children with T1D who don’t often see themselves represented, this doll will be a powerful role model, celebrating their strength and bringing recognition, inclusion and joy to their play.”
A growing legacy of inclusive design
Since the original Barbie’s debut in 1959, the brand has evolved to reflect greater diversity. The first Black Barbie dolls were introduced in the 1960s, followed by Hispanic dolls in the 1980s. From the 1990s onwards, Mattel expanded the range to include Barbies in under-represented careers such as astronauts and scientists.
It wasn’t until 2019 that Barbie dolls with visible disabilities were introduced. Since then, Mattel has launched more than 175 diverse Barbie looks as part of the Fashionistas range, which now includes dolls with hearing aids, prosthetic limbs, wheelchairs, vitiligo, and Down’s syndrome. A black Barbie with Down’s syndrome and a blind Barbie are also part of the line.
The diabetes Barbie doll continues that trend, offering children with the condition a chance to see themselves positively reflected in their toys.
Industry-wide shift toward representation
Barbie is not the only toy brand prioritising diversity. UK-based brand Lottie includes dolls with autism and Down’s syndrome, while Lego offers a variety of inclusive minifigures, including characters with physical and non-visible disabilities.
Arjun Panesar, founding chief executive of Diabetes.co.uk, praised Mattel’s decision, stating: “Representation matters – especially in childhood. Seeing a Barbie doll with type 1 diabetes helps normalise the condition, reduce stigma and show children that they are not alone.
“It’s a positive step forward in building confidence, inclusion and understanding around living with diabetes.”
Promoting empathy through play
The launch of the diabetes Barbie doll is not just about inclusion—it is also part of Mattel’s mission to extend the boundaries of imaginative play. The company says the goal is to encourage children to engage with experiences beyond their own, helping them to understand the challenges others may face.
As Barbie continues to evolve, the inclusion of realistic medical conditions such as type 1 diabetes signals a more inclusive future for toys and the children who play with them.
Keep ReadingShow less
Italian-born French fashion designer Elsa Schiaparelli
“In difficult times fashion is always outrageous.” – Elsa Schiaparelli.
The Victoria & Albert Museum has announced its first ever UK exhibition dedicated to Elsa Schiaparelli, the visionary designer who blurred the boundaries between fashion, art and performance. Titled Schiaparelli: Fashion Becomes Art, it runs from 21 March to 1 November 2026 in the Sainsbury Gallery and will draw on the V&A’s status as home to Britain’s National Collection of Dress and its foremost collection of Schiaparelli garments.
Vogue 1940; Designer Elsa Schiaparelli wearing black silk dress with crocheted collar of her own design and a turbanFredrich Baker/Condé Nast via Getty Images
Exhibition scope and highlights
Over 200 objects across media: garments, accessories, jewellery, perfume bottles, paintings, photographs, sculpture, furniture and archival sketches.
Iconic pieces on display:
The ‘Skeleton’ dress (with Salvador Dalí)
The ‘Tears’ dress and the surreal shoe hat (with Jean Cocteau)
Archive objects from Schiaparelli’s London branch, highlighting her dynamic UK clientele
Accompanying artworks by Pablo Picasso, Jean Cocteau and Man Ray
A survey of the brand’s modern era under creative director Daniel Roseberry, whose sculptural gowns have dressed Zendaya, Beyoncé, Lady Gaga and Doja Cat
“Schiaparelli’s collaboration with artists and the world of performance makes her an ideal subject,” said V&A Director Tristram Hunt, calling the show “a celebration of one of fashion’s most daring innovators.”
Delphine Bellini, CEO of Schiaparelli, adds: “Elsa Schiaparelli’s fearless imagination and radical vision redefined the boundaries between fashion and art.”
'Tears' Evening dress and head veil, designed by Elsa Schiaparelli, February 1938 for Circus Collection, summer 1938. Fabric designed by Salvador Dali Victoria and Albert Museum, London
From Paris salons to the Met Gala red carpet
Long before the V&A’s announcement, Natasha Poonawalla brought Schiaparelli’s surrealist drama to global attention. In 2022, she paired a gold Schiaparelli corset with a Sabyasachi sari, styled by Anaita Shroff Adajania. A year later, she returned to the Met Gala in a futuristic silver Schiaparelli gown, both moments underlining how Indian influencers are shaping today’s couture conversation.
Natasha Poonawalla attends The 2022 Met GalaGetty Images
Curators, press details and what’s next
Curated by Sonnet Stanfill, Lydia Caston and Rosalind McKever, the show is the first UK retrospective focusing on Schiaparelli’s output from the 1920s to 1954 and its present day revival.
Tickets on sale autumn 2025
Accompanied by a fully illustrated V&A catalogue, available autumn 2026
Part of the V&A’s major fashion exhibition series following Christian Dior: Designer of Dreams and Naomi: In Fashion
Vogue 1936; Two models, standing in a white room with arrows painted on walls and wearing dresses by Schiaparelli;Cecil Beaton/Condé Nast via Getty Images
What it means for South Asian style
This isn’t just a show for fashion students and couture fans. It’s a chance to see how a radical female designer redefined beauty and power, and how that legacy continues through Indian influencers like Poonawalla, who proudly bring together cultural identity with high fashion on the world stage.
Keep ReadingShow less
Lewis clarifies legal rights for online and in-store purchases
Martin Lewis flags incorrect return rights information on 30 retail websites
Retailers include New Look, The Range, and Selfridges
Lewis clarifies legal rights for online and in-store purchases
Trading Standards to be alerted following MoneySavingExpert.com investigation
Martin Lewis highlights return rights confusion
Money-saving expert Martin Lewis has issued a warning to UK consumers after uncovering misleading returns information on the websites of 30 major retailers, including New Look, The Range, and Selfridges.
Speaking on ITV1's Good Morning Britain, Lewis explained that several retailers are presenting incorrect information about return rights for online shoppers — in some cases, underplaying the legal protections customers are entitled to.
In a tweet posted after the segment aired, Lewis wrote: “30 retailers including Selfridges, New Look and The Range are publishing misleading (worse) return rights information on their websites than you legally have. Find which stores to be cautious with, and what your rights are.”
Legal rights for online shoppers
During his TV appearance, Martin Lewis clarified that consumers who shop online — as opposed to in-store — benefit from legal protections under the Consumer Contracts Regulations.
“If you buy something online, unless it is personalised or perishable, you have an absolute right to change your mind,” he said. “You have 14 days after delivery — important it’s after delivery, not after order — in which to tell the retailer you're returning it. Then you have another 14 days to send it back. That gives you up to 28 days.”
He also stressed the distinction between online and in-store shopping: “If you buy something in-store, you have no legal right to return it unless it’s faulty. Some shops do allow returns as part of their policy, and if they publish that, it becomes part of the contract. But legally, there is no obligation unless the item is defective.”
Incorrect wording found on retailer websites
Lewis and his team at MoneySavingExpert.com identified numerous cases where retailers had not correctly stated consumers’ legal rights on their websites.
One such example involved New Look, where the website stated: “You can return sale items within 14 days.” Lewis responded: “No! You can notify them within 14 days and you’ve got another 14 days to send it back.”
He also flagged a misleading policy by home and garden retailer The Range, which read: “You need to return your item to us at our Range marketplace partner within 14 days of receiving it.” Lewis explained: “No. You have 14 days from receiving it to notify that you’re returning it and a further 14 days to complete the return.”
He went on to say: “We found 30 examples. What’s really frustrating is that two of those — Monsoon and New Look — had the same issue back in 2018 when we last reviewed this. We notified them then, and they still have it wrong now. So we’re taking our evidence to Trading Standards.”
Retailers respond
In response to the findings, a spokesperson for New Look said: “We thank MoneySavingExpert.com for bringing this to our attention. While our current policies comply with statutory return rights, we have updated the wording on our website to ensure greater clarity for our customers. Customers have 14 days to notify us that they’ve changed their mind on items bought online in our sale, and a further 14 days to make the return.”
Consumers are encouraged to review their rights when shopping online and refer to trusted sources like the Money Saving Expert website for accurate advice. The full list of the 30 retailers identified can be found there.
The Daily Express has also contacted The Range and other retailers mentioned in the investigation for further comment.
Keep ReadingShow less
Collins accepted the findings of the ASA’s investigation
Instagram post by Gemma Collins promoting Yazen weight-loss service banned
ASA rules it breached regulations on promoting prescription-only medication
Eight other weight-loss ads also banned in regulatory crackdown
ASA bans Collins' Instagram advert
An Instagram post by TV personality Gemma Collins promoting a weight-loss drug and digital service has been banned by the UK’s advertising watchdog for breaching regulations around prescription-only medicines.
Collins had shared a promotional video on 6 January 2025, stating: “I’m starting this year two sizes down, thanks to Yazen’s weight loss app and medication.” The Advertising Standards Authority (ASA) ruled that the post unlawfully promoted prescription-only medication to the public.
Prescription medication references breached rules
Yazen, a Swedish digital healthcare company, provides a doctor-supervised weight-loss programme which includes prescription drugs alongside lifestyle coaching. While Collins did not name a specific drug in the advert, she referenced the medication being “prescribed on the NHS”.
The ASA said it consulted the Medicines and Healthcare products Regulatory Agency (MHRA), which concluded that viewers were likely to interpret the advert as encouragement to seek prescription weight-loss medication.
As a result, the ASA found that the advert breached its code by promoting prescription-only treatments directly to the public. This type of promotion is prohibited under UK advertising regulations.
Collins accepted the findings of the ASA’s investigation and confirmed that she would follow the relevant guidance in future social media promotions.
Eight other ads also banned
Collins’ post was one of nine adverts banned in the ASA’s latest enforcement action targeting weight-loss drug promotions. The watchdog stated that all of the adverts promoted prescription-only treatments to consumers, a practice not allowed under UK law.
The other banned adverts included:
A Meta ad by CheqUp Health stating: “Take the first step to sustainable weight loss with CheqUp.”
A Meta ad by HealthExpress.co.uk, featuring an injection pen image and rule-breaching claims.
A Google ad for Juniper UK describing “GLP-1 Weekly Weight Loss Injection” with an injection pen image.
Two Google ads for Phlo Clinic, one offering “35% off Weight Loss Order” and another promoting “Weight loss Injections.”
A Google ad for SemaPen claiming, “SemaPen Makes Weight Loss Easier.”
A Meta ad by Cloud Pharmacy using text message imagery referencing new weight-loss medication.
A Google ad for pharmacyonline.co.uk stating “Obesity Treatment Jab” with an image of a medication vial.
The ASA ruled that none of these adverts should appear again in their current form. The regulator said it will continue to monitor the promotion of weight-loss services involving prescription medication, particularly on digital platforms.